Lecture 10 - T-cell mediated responses II Flashcards
Tregs: what do they do, what are the types, and what is their master transcription factor?
Suppress harmful T-cell responses - prevent self-recognising CD4+ T-cells from triggering an immune response
- Foxp3+ - CD4+/CD25+, the ‘typical’ Treg with the Foxp3 master TF
- Tr1 - CD4+/Foxp3-, produced by IL-10 stimulation, secrete IL-10 and TGFβ
- Th3 - CD4+/Foxp3-, produce large amounts of TGFβ
Foxp3+ Tregs: what do they present on their surface, what are the types, and how are they developed?
CD4+ and CD25+
- natural/thymic Tregs (nTregs/tTregs)
- Induced/peripheral Tregs (iTregs/pTregs)
In the thymus:
* Two-step model
* TGFβ dependent
In the periphery:
* TGF-β dependent - TGF-β, IL-2, retinoic acid, vitamin D (the latter three require TGF-β presence)
Thymus Treg development: what are the mechanisms of the Two-step model?
- Strong TCR engagement leads to upregulation of CD25
- CD25 is a high affinity IL2R and will react to IL-2 which promotes Foxp3 expression
Thymus Treg development: what are the mechanisms of the TGFβ-dependent model?
- TCR stimulus in the thymus along with TGFβ signalling results in Foxp3 expression
Periphery Treg development: what are the mechanisms?
TGF-β dependent, the molecules promoting Treg development require TGF-β presence:
* TGF-β
* IL-2
* Retinoic acid
* Vitamin D
Tr1 cells: what are their surface markers, what are they produced by and what do they secrete?
CD4+ (Foxp3-)
Produced by IL-10 stimulation
Secrete IL-10 and TGFβ
Th3 cells: what are their surface markers and what do they secrete?
CD4+ (Foxp3-)
Secrete large amounts of TGFβ
IPEX: what is it and what happens if you have it?
Immunodysregulation polyendocrinopathy enteropathy X-linked syndrome
Malfunctions in Tregs - often result in autoimmune diseases
Foxp3+ Tregs: how do they suppress T cells?
- Cytokine dependent - produce TGF-β and IL-10, suppressing activated T-cells or preventing T-cells from becoming activated
- Induction of effector T-cell death - Granzymes/perforin induce cell death
- Disruption of effector T-cell metabolism - Taking up IL-2 and preventing T-cells from getting the required survival signal and converting ATP to adenosine, removing a T-cell energy source
- Targeting of dendritic cells - binding B7 on DCs and preventing TC-DC association
Cytokine dependent T-cell suppression
Produce TGF-β and IL-10 (anti-proliferative cytokines), suppressing activated T-cells or preventing T-cells from becoming activated
Induction of effector T-cell death
Perforin and granzyme secretion causes apoptosis of T-cells
Disruption of effector T-cell metabolism
- Take up IL-2 at a greater rate than CD4+ T-cells through CD25+ so they can’t become activated
- Can also produce adenosine from ATP which inhibits energy-requiring T-cells
Targeting of dendritic cells to suppress T-cells
CTLA4 binds to CD80 and CD86 (signal 2 of T-cell activation) with higher affinity, making it unavailable for T-cells by both downregulating it and transendocytosis
CTLA-4
Cytotoxic T-lymphocyte-associated protein
Treg plasticity: are Tregs able to present multiple T-cell TFs, why, and what is a TF that is expressed in all Tregs?
Foxp3+ should be unable to become another type of T-cell - however hybrid Tregs can occur (ie Foxp3 and T-bet)
Hybrid Tregs become hyper-specialised to shut down the type it is (T-bet hybrid can be localised better to Th1 areas and can then shut them down more efficiently)
GATA3 is expressed in all Tregs